Giuseppe Argenziano, MD, PhD
Dermatology — Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli, Italy
Giuseppe Argenziano
LeadR Profile
Dermatology
Subspecialties: Oncology - Public Health - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Short Biography
Giuseppe Argenziano is Full Professor and Head of the Dermatology Unit at the University of Campania, Naples, Italy; Editor-in-Chief of Dermatology Practical and Conceptual Journal; Co-founder and past president of the International Dermoscopy Society; Co-founder of the Italian Federation of Dermatological Societies; and past president of the Italian Society of Dermatology.
His main research field is dermato-oncology, being author of numerous scientific articles and books concerning dermoscopy, melanoma and non-melanoma skin cancer. As coordinator of the Melanoma Unit at the Campania University, he has established a successful tertiary, multidisciplinary, referral center particularly devoted to the diagnosis and management of patients with skin cancer.
Over the past 30 years he has supervised over 500 foreign and Italian residents in Dermatology, established scientific collaborations with 1500+ colleagues from more than 50 Nations, and organized more than 500 national and international didactic meetings, courses and conferences.
Professor Argenziano has authored more than 1000 full scientific articles and produced landmark primary publications and books in the field of skin cancer and dermoscopy. Over the past 30 years he has been invited as speaker and/or chairman in more than 1000 national and international conferences in the field of dermatology. His combined publications have received a sum total of 30.000+ citations with an h-index value of 83 (Scopus 2026).
Organizations
Career arc: 2015 - 2026
Number : 1148
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Why does classic scabies spare the adult scalp? A site-specific barrier hypothesis. scabies, skin microbiome | Dermatol Reports | 2026 | 0 |
| Melanoma characteristics according to clinical or dermoscopic image comparison in high-risk patients. sexually transmitted diseases, melanoma, skin diseases, dermoscopy | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Clinical and Dermoscopic Presentation of Rhabdomyomatous Mesenchymal Hamartoma: Differential Diagnosis and Review of the Literature. diagnosis, differential, diagnosis, hamartoma | Dermatol Pract Concept | 2026 | 0 |
| Dermoscopic Hallmarks of Lymphomatoid Papulosis: A Case Series of Five Histopathologically Proven Lesions. lymphomatoid papulosis, wounds and injuries | Dermatol Pract Concept | 2026 | 0 |
| Childhood Rosacea: Clinical, Diagnostic, and Therapeutic Insights into an Underestimated Pediatric Condition. skin, granuloma, rosacea, skin diseases, diagnosis, therapeutics, child | Dermatol Pract Concept | 2026 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Phase 3 Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to 12 Years of Age With Severe Alopecia Areata 2024-515438-33-00 — safety, alopecia areata, child, alopecia | Phase 3 | Active not recruiting | 2026 |
| A phase II open label study improving compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (BCC) the SONIBEC trial 2024-516797-29-00 — cells, therapeutics, carcinoma, basal cell, carcinoma | Phase 2 | Active not recruiting | 2021 |
| A phase II study of Sonidegib in Nevoid Basal Cell Carcinoma Syndrome (Gorlin) syndrome and sporadic BCC patients in EADO stage IIb SIBLINGS TRIAL 2024-515989-14-00 — cells, basal cell nevus syndrome, siblings, carcinoma, basal cell, carcinoma | Phase 2 | Recruiting | 2025 |
| Long term Assessment of Chlormethine Gel in Mycosis Fungoides NCT07046663 — cells, mycosis fungoides, lymphoma, cohort studies, lymphoma, t-cell, cutaneous, mycoses, mechlorethamine, therapeutics, lymphoma, t-cell, peripheral, t-lymphocytes, lymphoma, t-cell | N/A | Not yet recruiting | 2025 |
| Comparison of LimpiAD Cream 2 5 Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis NCT05971355 — skin, dermatitis, hyaluronic acid, eczema, emollients, pruritus, seizures, therapeutics, pharmaceutical vehicles, dermatitis, atopic | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map